Restricted accessResearch articleFirst published online 2016-07
Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells,Adipose Tissue-Derived Stem Cells,and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis
The use of human mesenchymal stem cells (hMSCs) has emerged as a possible therapeutic strategy for CNS-related conditions. Research in the last decade strongly suggests that MSC-mediated benefits are closely related with their secretome. Studies published in recent years have shown that the secretome of hMSCs isolated from different tissue sources may present significant variation. With this in mind, the present work performed a comparative proteomic-based analysis through mass spectrometry on the secretome of hMSCs derived from bone marrow (BMSCs), adipose tissue (ASCs), and human umbilical cord perivascular cells (HUCPVCs). The results revealed that BMSCs, ASCs, and HUCPVCs differed in their secretion of neurotrophic, neurogenic, axon guidance, axon growth, and neurodifferentiative proteins, as well as proteins with neuroprotective actions against oxidative stress, apoptosis, and excitotoxicity, which have been shown to be involved in several CNS disorder/injury processes. Although important changes were observed within the secretome of the cell populations that were analyzed, all cell populations shared the capability of secreting important neuroregulatory molecules. The difference in their secretion pattern may indicate that their secretome is specific to a condition of the CNS. Nevertheless, the confirmation that the secretome of MSCs isolated from different tissue sources is rich in neuroregulatory molecules represents an important asset not only for the development of future neuroregenerative strategies but also for their use as a therapeutic option for human clinical trials.
Get full access to this article
View all access options for this article.
References
1.
DragoD, CossettiC, IraciN, GaudeE, MuscoG, BachiA and PluchinoS. (2013). The stem cell secretome and its role in brain repair. Biochimie, 95:2271–2285.
2.
DeLanyJP, FloydZE, ZvonicS, SmithA, GravoisA, ReinersE, WuX, KilroyG, LefevreM and GimbleJM. (2005). Proteomic analysis of primary cultures of human adipose-derived stem cells: modulation by Adipogenesis. Mol Cell Proteomics, 4:731–740.
3.
ZvonicS, LefevreM, KilroyG, FloydZE, DeLanyJP, KheterpalI, GravoisA, DowR, WhiteA, WuX and GimbleJM. (2007). Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics, 6:18–28.
4.
NakanoN, NakaiY, SeoTB, YamadaY, OhnoT, YamanakaA, NagaiY, FukushimaM, SuzukiY, NakataniT and IdeC. (2010). Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett, 483:57–61.
5.
EgashiraY, SugitaniS, SuzukiY, MishiroK, TsurumaK, ShimazawaM, YoshimuraS, IwamaT and HaraH. (2012). The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res, 1461:87–95.
6.
LinYC, KoTL, ShihYH, LinMY, FuTW, HsiaoHS, HsuJY and FuYS. (2011). Human umbilical mesenchymal stem cells promote recovery after ischemic stroke. Stroke, 42:2045–2053.
7.
ShettyP, CooperK and ViswanathanC. (2010). Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J Transfus Sci, 4:14–24.
8.
NakanishiC, NagayaN, OhnishiS, YamaharaK, TakabatakeS, KonnoT, HayashiK, KawashiriMA, TsubokawaT and YamagishiM. (2011). Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow. Circ J, 75:2260–2268.
9.
RibeiroCA, FragaJS, GraosM, NevesNM, ReisRL, GimbleJM, SousaN and SalgadoAJ. (2012). The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res Ther, 3:18.
10.
HsiehJY, WangHW, ChangSJ, LiaoKH, LeeIH, LinWS, WuCH, LinWY and ChengSM. (2013). Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One, 8:e72604.
11.
FragaJS, SilvaNA, LourencoAS, GoncalvesV, NevesNM, ReisRL, RodriguesAJ, ManadasB, SousaN and SalgadoAJ. (2013). Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations. Biochimie, 95:2297–2303.
12.
SilvaNA, GimbleJM, SousaN, ReisRL and SalgadoAJ. (2013). Combining adult stem cells and olfactory ensheathing cells: the secretome effect. Stem Cells Dev, 22:1232–1240.
13.
SarugaserR, LickorishD, BakshD, HosseiniMM and DaviesJE. (2005). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 23:220–229.
14.
DuboisSG, FloydEZ, ZvonicS, KilroyG, WuX, CarlingS, HalvorsenYD, RavussinE and GimbleJM. (2008). Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. Methods Mol Biol, 449:69–79.
15.
ManadasBJ, VougasK, FountoulakisM and DuarteCB. (2006). Sample sonication after trichloroacetic acid precipitation increases protein recovery from cultured hippocampal neurons, and improves resolution and reproducibility in two-dimensional gel electrophoresis. Electrophoresis, 27:1825–1831.
16.
CollinsBC, GilletLC, RosenbergerG, RostHL, VichalkovskiA, GstaigerM and AebersoldR. (2013). Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat Methods, 10:1246–1253.
17.
YuB, ZhangX and LiX. (2014). Exosomes derived from mesenchymal stem cells. Int J Mol Sci, 15:4142–4157.
18.
BaglioSR, PegtelDM and BaldiniN. (2012). Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol, 3:359.
19.
Gonzalez-BegneM, LuB, HanX, HagenFK, HandAR, MelvinJE and YatesJR. (2009). Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res, 8:1304–1314.
20.
KimHS, ChoiDY, YunSJ, ChoiSM, KangJW, JungJW, HwangD, KimKP and KimDW. (2012). Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res, 11:839–849.
21.
CambyI, Le MercierM, LefrancF and KissR. (2006). Galectin-1: a small protein with major functions. Glycobiology, 16:137R–157R.
22.
GeYS, TengWY and ZhangCD. (2009). Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25–35)-induced oxidative stress in PC12 cells. Chin Med J (Engl), 122:716–724.
TeramotoS, ShimuraH, TanakaR, ShimadaY, MiyamotoN, AraiH, UrabeT and HattoriN. (2013). Human-derived physiological heat shock protein 27 complex protects brain after focal cerebral ischemia in mice. PLoS One, 8:e66001.
25.
OhY, KimEY, KimY, JinJ, JinBK, JahngGH, JungMH, ParkC, KangI, HaJ and ChoeW. (2011). Neuroprotective effects of overexpressed cyclophilin B against Abeta-induced neurotoxicity in PC12 cells. Free Radic Biol Med, 51:905–920.
26.
ShimadaY, TanakaR, ShimuraH, YamashiroK, UrabeT and HattoriN. (2014). Phosphorylation enhances recombinant HSP27 neuroprotection against focal cerebral ischemia in mice. Neuroscience, 278:113–121.
27.
KahlePJ, WaakJ and GasserT. (2009). DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic Biol Med, 47:1354–1361.
28.
YanagisawaD, KitamuraY, IndenM, TakataK, TaniguchiT, MorikawaS, MoritaM, InubushiT, TooyamaI, et al. (2008). DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J Cereb Blood Flow Metab, 28:563–578.
29.
HattoriI, TakagiY, NakamuraH, NozakiK, BaiJ, KondoN, SuginoT, NishimuraM, HashimotoN and YodoiJ. (2004). Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal, 6:81–87.
TizonB, SahooS, YuH, GauthierS, KumarAR, MohanP, FigliolaM, PawlikM, GrubbA, et al.(2010). Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One, 5:e9819.
32.
LeeYM, ParkSH, ShinDI, HwangJY, ParkB, ParkYJ, LeeTH, ChaeHZ, JinBK, OhTH and OhYJ. (2008). Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem, 283:9986–9998.
33.
GumET, SwansonRA, AlanoC, LiuJ, HongS, WeinsteinPR and PanterSS. (2004). Human serum albumin and its N-terminal tetrapeptide (DAHK) block oxidant-induced neuronal death. Stroke, 35:590–595.
34.
LandryJ, ChretienP, LambertH, HickeyE and WeberLA. (1989). Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol, 109:7–15.
35.
EllisRJ. (1990). The molecular chaperone concept. Semin Cell Biol, 1:1–9.
36.
ChauhanV, JiL and ChauhanA. (2008). Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease. Biogerontology, 9:381–389.
37.
QuWS, WangYH, WangJP, TangYX, ZhangQ, TianDS, YuZY, XieMJ and WangW. (2010). Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochem Res, 35:1716–1724.
38.
TizonB, RibeEM, MiW, TroyCM and LevyE. (2010). Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J Alzheimers Dis, 19:885–894.
39.
XuL, ShengJ, TangZ, WuX, YuY, GuoH, ShenY, ZhouC, ParaoanL and ZhouJ. (2005). Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol Dis, 18:152–165.
40.
YamashitaT, SawamotoK, SuzukiS, SuzukiN, AdachiK, KawaseT, MiharaM, OhsugiY, AbeK and OkanoH. (2005). Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem, 94:459–468.
41.
SchabitzWR, SommerC, ZoderW, KiesslingM, SchwaningerM and SchwabS. (2000). Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke, 31:2212–2217.
42.
BoehmJE, ChaikaOV and LewisRE. (1998). Anti-apoptotic signaling by a colony-stimulating factor-1 receptor/insulin receptor chimera with a juxtamembrane deletion. J Biol Chem, 273:7169–7176.
43.
LeHT, HirkoAC, ThinschmidtJS, GrantM, LiZ, PerisJ, KingMA, HughesJA and SongS. (2011). The protective effects of plasma gelsolin on stroke outcome in rats. Exp Transl Stroke Med, 3:13.
44.
ZendedelA, NobakhtM, BakhtiyariM, BeyerC, KippM, BaazmM and JoghataieMT. (2012). Stromal cell-derived factor-1 alpha (SDF-1alpha) improves neural recovery after spinal cord contusion in rats. Brain Res, 1473:214–226.
45.
MehtaA, PrabhakarM, KumarP, DeshmukhR and SharmaPL. (2013). Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol, 698:6–18.
46.
DeCosterMA, SchabelmanE, Tombran-TinkJ and BazanNG. (1999). Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons. J Neurosci Res, 56:604–610.
47.
DocagneF, NicoleO, GabrielC, Fernandez-MonrealM, LesneS, AliC, PlawinskiL, CarmelietP, MacKenzieET, BuissonA and VivienD. (2002). Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Mol Cell Neurosci, 21:634–644.
48.
YamadaM and HatanakaH. (1994). Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res, 643:173–180.
49.
ToulmondS, VigeX, FageD and BenavidesJ. (1992). Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett, 144:49–52.
50.
YabeT, SanagiT and YamadaH. (2010). The neuroprotective role of PEDF: implication for the therapy of neurological disorders. Curr Mol Med, 10:259–266.
51.
DupontDM, MadsenJB, KristensenT, BodkerJS, BlouseGE, WindT and AndreasenPA. (2009). Biochemical properties of plasminogen activator inhibitor-1. Front Biosci (Landmark Ed), 14:1337–1361.
52.
WilkinsonKD, LeeKM, DeshpandeS, Duerksen-HughesP, BossJM and PohlJ. (1989). The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science, 246:670–673.
53.
SetsuieR and WadaK. (2007). The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int, 51:105–111.
54.
TaiHC and SchumanEM. (2008). Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci, 9:826–838.
55.
TianL, NieH, ZhangY, ChenY, PengZ, CaiM, WeiH, QinP, DongH and XiongL. (2014). Recombinant human thioredoxin-1 promotes neurogenesis and facilitates cognitive recovery following cerebral ischemia in mice. Neuropharmacology, 77:453–464.
56.
Wagenaar-BosIG and HackCE. (2006). Structure and function of C1-inhibitor. Immunol Allergy Clin North Am, 26:615–632.
57.
De SimoniMG, StoriniC, BarbaM, CatapanoL, ArabiaAM, RossiE and BergamaschiniL. (2003). Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab, 23:232–239.
58.
MinorK, TangX, KahrilasG, ArchibaldSJ, DaviesJE and DaviesSJ. (2008). Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons. Neurobiol Dis, 32:88–95.
59.
YerburyJJ and WilsonMR. (2010). Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Abeta(1–42) toxicity and uptake. Cell Stress Chaperones, 15:115–121.
60.
TeixeiraFG, CarvalhoMM, SousaN and SalgadoAJ. (2013). Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?. Cell Mol Life Sci, 70:3871–3882.
61.
SatohT, NakamuraS, TagaT, MatsudaT, HiranoT, KishimotoT and KaziroY. (1988). Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol, 8:3546–3549.
62.
Tombran-TinkJ, ChaderGG and JohnsonLV. (1991). PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res, 53:411–414.
63.
GaoX, BianW, YangJ, TangK, KitaniH, AtsumiT and JingN. (2001). A role of N-cadherin in neuronal differentiation of embryonic carcinoma P19 cells. Biochem Biophys Res Commun, 284:1098–1103.
64.
HouenouLJ, D'CostaAP, LiL, TurgeonVL, EnyadikeC, AlberdiE and BecerraSP. (1999). Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J Comp Neurol, 412:506–514.
65.
PasterkampRJ, PeschonJJ, SpriggsMK and KolodkinAL. (2003). Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature, 424:398–405.
66.
ReinhardE, SuidanHS, PavlikA and MonardD. (1994). Glia-derived nexin/protease nexin-1 is expressed by a subset of neurons in the rat brain. J Neurosci Res, 37:256–270.
67.
KorshunovaI, CaroniP, KolkovaK, BerezinV, BockE and WalmodPS. (2008). Characterization of BASP1-mediated neurite outgrowth. J Neurosci Res, 86:2201–2213.
68.
FarmerL, SommerJ and MonardD. (1990). Glia-derived nexin potentiates neurite extension in hippocampal pyramidal cells in vitro. Dev Neurosci, 12:73–80.
69.
HuangQ, ShurBD and BegovacPC. (1995). Overexpressing cell surface beta 1.4-galactosyltransferase in PC12 cells increases neurite outgrowth on laminin. J Cell Sci, 108 (Pt 2):839–847.
70.
ShenA, YanJ, DingF, GuX, ZhuD and GuJ. (2003). Overexpression of beta-1,4-galactosyltransferase I in rat Schwann cells promotes the growth of co-cultured dorsal root ganglia. Neurosci Lett, 342:159–162.
PujolF, KitabgiP and BoudinH. (2005). The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J Cell Sci, 118:1071–1080.
73.
MalikAR, UrbanskaM, GozdzA, SwiechLJ, NagalskiA, PeryczM, BlazejczykM and JaworskiJ. (2013). Cyr61, a matricellular protein, is needed for dendritic arborization of hippocampal neurons. J Biol Chem, 288:8544–8559.
74.
NandiS, GokhanS, DaiXM, WeiS, EnikolopovG, LinH, MehlerMF and StanleyER. (2012). The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev Biol, 367:100–113.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
